Zydus Lifesciences Limited has informed the Exchange regarding a press release dated August 08, 2025, titled "Zydus receives final approval from USFDA for Prucalopride Tablets, 1 mg and 2 mg".
Press Release Aug 08 2025
Filed with NSE ·
6ix hasn’t read this filing yet.
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release Aug 07 2025
- Press Release Jul 29 2025
- Press Release Jul 24 2025
- Press Release 17-07-2025 NewspaperpublicationAGMnotice17072025
- Press Release Jul 16 2025
Later from Zydus Lifesciences
- Press Release Aug 11 2025
- Press Release Aug 12 2025
- Press Release Aug 13 2025
- Press Release 20-08-2025 Newspaperadvertisement20082025
- Zydus Therapeutics Reports Positive Topline Results from EPICS-III Phase 2(b)/3 Trial of Saroglitazar Magnesium in Patients with Primary Biliary Cholangitis
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences